Drugs / Ankaferd Hemostat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07792473 | Sep 2026 → Feb 2027 expected | mouth mucosa disorder | University of Yalova | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ankaferd Hemostat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07792473 ↗ |
| Route | Topical | “Ankaferd Hemostat will be used as a topical oral care intervention.” NCT07792473 ↗ |